KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Equity (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Return on Equity for 6 consecutive years, with 0.22% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 28.0% year-over-year to 0.22%, compared with a TTM value of 0.22% through Sep 2025, up 28.0%, and an annual FY2024 reading of 0.02%, up 21.0% over the prior year.
  • Return on Equity was 0.22% for Q3 2025 at Aurinia Pharmaceuticals, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.22% in Q3 2025 and bottomed at 0.6% in Q3 2021.
  • Average Return on Equity over 5 years is 0.2%, with a median of 0.2% recorded in 2023.
  • The sharpest move saw Return on Equity dropped -21bps in 2021, then surged 33bps in 2022.
  • Year by year, Return on Equity stood at 0.47% in 2021, then soared by 44bps to 0.26% in 2022, then grew by 22bps to 0.2% in 2023, then soared by 107bps to 0.02% in 2024, then soared by 1378bps to 0.22% in 2025.
  • Business Quant data shows Return on Equity for AUPH at 0.22% in Q3 2025, 0.18% in Q2 2025, and 0.11% in Q1 2025.